By Rhythma Kaul, New Delhi
UPDATED ON MAR 25, 2021 04:59 AM IST
New variant detected in Maharashtra, says govt; total of 771 ‘variants of concern’ seen in 18 states amid surge in daily cases
PUBLISHED ON MAR 14, 2021 03:22 PM IST
The study, published in the journal PLOS Biology, assessed hundreds of thousands of sequenced genomes of the Sars-CoV-2 virus and found that for the first 11 months of the Covid-19 pandemic, there has been very little 'important genetic change'.
By Zarafshan Shiraz
UPDATED ON MAR 05, 2021 06:41 PM IST
- As the new coronavirus variants spread and Covid-19 symptoms continue to increase and expand, here’s how you can locate the infection through these four kinds of skin changes
ANI | , Washington [us]
PUBLISHED ON FEB 26, 2021 05:25 PM IST
A new study published in Biophysical Society, introduces new molecular models to show what parts of SARS-CoV-2 are critical for that interaction, revealing new potential drug targets for the infection.
By HT Correspondent, New Delhi
PUBLISHED ON FEB 05, 2021 03:15 AM IST
The study was carried out by looking at the case of an immunocompromised patient, who had a recurrent infection for 74 days before ultimately succumbing to the disease.
UPDATED ON FEB 03, 2021 08:18 AM IST
A new research has provided some reassurance that swift cases of reinfection will be rare as scientists find antibodies persisting for long in those infected with Covid-19 previously
ANI | , Bristol
PUBLISHED ON JAN 30, 2021 07:48 AM IST
- A new study done in Bristol shows how dietary supplements and compounds might be able to bind to the virus and, as a result, make it less infective.
Hindustan Times, New Delhi | By HT Correspondent | Edited by Joydeep Sen Gupta
UPDATED ON OCT 21, 2020 11:53 AM IST
Flu-like symptoms can be caused by several viruses, including the influenza virus, rhinovirus, and even some coronaviruses other than Sars-CoV-2, which causes Covid-19. However, the influenza viruses and coronaviruses belong to two different families
Antibodies from patients infected with SARS-CoV in 2003 cross-neutralised SARS-CoV-2 in vitro: Study
Washington | By Asian News International| Posted by Susmita Pakrasi
UPDATED ON OCT 10, 2020 02:15 PM IST
The authors also report that, surprisingly, mice and rabbits immunised with a receptor-binding domain (RBD) from a strain of SARS-CoV that infects the Himalayan palm civet elicited stronger antibody responses against SARS-CoV-2 than animals immunised with an RBD from a human SARS-CoV strain.